Crenessity CAH denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for crenessity cah are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for Crenessity in CAH — and What to Do When It's Denied

Blue Cross Blue Shield requires prior authorization for Crenessity (tildacerfont) because it is a specialty medication for congenital adrenal hyperplasia — a rare condition — and the plan wants to verify that the patient meets its coverage criteria before paying for a high-cost drug. A prior-authorization denial at the initial stage means the submitted request was incomplete, or the documentation did not satisfy one or more of the plan's stated criteria.

Prior-auth denials for Crenessity are frequently overturned on appeal when a complete, well-organized clinical package is submitted — one that addresses each criterion in BCBS's published medical policy directly and specifically.

## Federal Appeal Rights

• ACA §2719 external review: After exhausting internal appeals, you may request independent external review within approximately four months of the final denial notice — verify the exact deadline on your denial letter. Expedited review is available when waiting for the standard process would seriously harm your health.
• ERISA §503: If covered through an employer plan, you are entitled to a full-and-fair review with a written explanation of which criteria were not met and why.
• Urgent/concurrent review: If you are currently taking Crenessity or your condition is acute, ask specifically about the expedited or concurrent review process, which has a faster turnaround than standard appeal.

## Concrete Appeal Steps

1. Obtain BCBS's current prior-authorization criteria for Crenessity. This is the document your prescriber's office must address point by point. Call the number on the denial letter or access BCBS's provider portal. 2. Request a detailed medical-necessity letter from your prescriber (ideally an endocrinologist). The letter must cite the specific BCBS criteria by name or number and answer each with a fact from the medical record. 3. Assemble the documentation package: - Confirmed CAH diagnosis (genetic or biochemical documentation) - Specialist clinical notes - Current and prior treatment history with dates and chart-documented outcomes - Relevant recent lab results and clinical markers from the chart - The prescriber's letter 4. File the appeal within the plan's stated deadline (on the denial notice), with a criteria-mapping cover sheet.

## Criteria-Mapping Structure

For each item in BCBS's PA criteria for Crenessity:

| BCBS PA Criterion | Supporting Documentation | |---|---| | Confirmed CAH diagnosis | Genetic/biochemical confirmation, diagnosis codes | | Specialist management (endocrinology) | Prescribing physician's specialty and notes | | Inadequate control or clinical indication | Chart notes and recent labs showing disease status | | Prior therapy history | Medication list with dates and documented responses | | Prescriber attestation | Medical-necessity letter signed by prescriber |

Verify the exact current PA criteria from BCBS before submitting — criteria are revised periodically, and your letter must address the version in effect on the denial date.